TY  - JOUR 
AU  - Mateos Manteca, María Victoria
AU  - Oriol, Albert
AU  - Martínez-López, Joaquín
AU  - Gutiérrez Gutiérrez, Norma Carmen
AU  - Teruel, Ana-Isabel
AU  - López de la Guía, Ana
AU  - López, Javier
AU  - Bengoechea, Enrique
AU  - Pérez, Montserrat
AU  - Polo, Marta
AU  - Palomera, Luis
AU  - De Arriba, Felipe
AU  - González, Yolanda
AU  - Hernández, José-Mariano
AU  - Granell, Miquel
AU  - Bello, José-Luis
AU  - Bargay, Joan
AU  - Peñalver, Francisco-Javier
AU  - Ribera, José-María
AU  - Martín-Mateos, María-Luisa
AU  - García Sanz, Ramón
AU  - Lahuerta, Juan José
AU  - Bladé, Joan
AU  - San Miguel Izquierdo, Jesús Fernando
PY  - 2012
UR  - http://hdl.handle.net/10366/154315
AB  - [EN]Maintenance therapy has become a hot field in myeloma, and it may be particularly relevant in elderly patients because the major benefit results from the initial therapy. We report the results of a randomized comparison of maintenance with...
LA  - eng
PB  - American Society of Hematology
KW  - Mieloma múltiple
KW  - Chromosome Aberrations
KW  - Aged
KW  - Boronic Acids
KW  - Follow-Up Studies
KW  - Humans
KW  - Pyrazines
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Prognosis
KW  - Multiple Myeloma
KW  - Maintenance Chemotherapy
KW  - Thalidomide
KW  - In Situ Hybridization
KW  - Prednisone
KW  - Remission Induction
KW  - Survival Rate
TI  - Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
DO  - 10.1182/blood-2012-05-427815
T2  - Blood
VL  - 120
M2  - 2581
ER  -